This gain-of-function mechanism is opposite to the situation in Dravet syndrome, where loss-of-function mutations in SCN1A are most common (Meisler et al. 2016). The gene discussed is SCN1A; the disease is encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.